Similar Items: Proactive identification of candidates for newly approved targeted therapies using a clinical decision support program
- Antidiabetic agents as potential cytotoxic candidates for cancer therapy
- Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
- Phase II Trial of an Orelabrutinib-Based Combination Therapy in Newly Diagnosed Primary Central Nervous System Lymphoma
- Research on Targeted Therapy for Malignant Tumors of the Biliary Tract
- Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia
- Vitamin D should be considered as a targeted therapy in glioblastoma cases